EMA says J&J linked to ‘rare’ clot, but benefits outweigh risks

0
152

by Danny KEMP THE HAGUE, Netherlands (AFP) — Blood clots should be listed as a “very rare” side effect of the Johnson & Johnson coronavirus vaccine but its benefits still outweigh the risks, the EU’s drug watchdog said Tuesday. The European Medicines Agency (EMA) said in a statement that it had found a “possible link” between the J&J jab and the clots, following eight such cases in the United States, one of which was fatal. […]